Monday, November 28, 2016

BRIEF-Nature Cell receives FDA approval for early and mid-stage alzheimer's clinical trial

* Nature Cell Co Ltd receives U.S. FDA approval for phase I

and II alzheimer's clinical trial

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)